DNA
Ginkgo Bioworks Holdings, Inc.
NYSE Biological Products, (No Diagnostic Substances) Accelerated filer

Key Financials

Operating Income
$-315278000
↑ 43.7%
Revenue
$170.2M
↓ 25.1%
EPS (Diluted)
$-5.64
↑ 46.5%
Shareholders' Equity
$508.6M
↓ 29.0%
Total Liabilities
$611.1M
↓ 7.6%
Net Income
$-312763000
↑ 42.8%
Cash & Equivalents
$167.2M
↓ 70.2%
Operating Cash Flow
$-171059000.00
↑ 46.5%

Recent SEC Filings

Form Type Filed Date Link
4 10/7/2026 View on SEC
144 10/5/2026 View on SEC
144 9/17/2026 View on SEC
4 9/16/2026 View on SEC
144 9/15/2026 View on SEC
4 8/25/2026 View on SEC
144 8/24/2026 View on SEC
144 8/17/2026 View on SEC
10-Q 8/6/2026 View on SEC
8-K 8/5/2026 View on SEC

Company Information

Field Value
Ticker DNA
Company Name Ginkgo Bioworks Holdings, Inc.
CIK 1830214
Sector Biological Products, (No Diagnostic Substances)
Industry Accelerated filer
Exchange NYSE
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (877) 442-5362